JP2011503142A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503142A5 JP2011503142A5 JP2010533564A JP2010533564A JP2011503142A5 JP 2011503142 A5 JP2011503142 A5 JP 2011503142A5 JP 2010533564 A JP2010533564 A JP 2010533564A JP 2010533564 A JP2010533564 A JP 2010533564A JP 2011503142 A5 JP2011503142 A5 JP 2011503142A5
- Authority
- JP
- Japan
- Prior art keywords
- tigecycline
- type
- crystal
- hydrochloride
- tigecycline hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004089 tigecycline Drugs 0.000 description 32
- FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- 239000013078 crystal Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000002924 anti-infective effect Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000013583 drug formulation Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- -1 tigecycline hydrochlorides Chemical class 0.000 description 1
- 229940061267 tygacil Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07120732 | 2007-11-14 | ||
| EP07120732.8 | 2007-11-14 | ||
| PCT/EP2008/065398 WO2009062963A1 (en) | 2007-11-14 | 2008-11-12 | Crystalline forms of tigecycline hydrochloride |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011503142A JP2011503142A (ja) | 2011-01-27 |
| JP2011503142A5 true JP2011503142A5 (enExample) | 2014-05-01 |
| JP5574967B2 JP5574967B2 (ja) | 2014-08-20 |
Family
ID=39186791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010533564A Active JP5574967B2 (ja) | 2007-11-14 | 2008-11-12 | チゲサイクリン塩酸塩の結晶型 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8252946B2 (enExample) |
| EP (1) | EP2220033B1 (enExample) |
| JP (1) | JP5574967B2 (enExample) |
| CN (1) | CN101861300B (enExample) |
| CA (1) | CA2704536C (enExample) |
| ES (1) | ES2532880T3 (enExample) |
| IL (1) | IL205451A0 (enExample) |
| SI (1) | SI2220033T1 (enExample) |
| WO (1) | WO2009062963A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102285898A (zh) * | 2011-06-29 | 2011-12-21 | 赵军旭 | 替加环素盐酸盐的晶型及其制备方法 |
| CN106431963B (zh) * | 2015-08-13 | 2019-03-05 | 江苏豪森药业集团有限公司 | 替加环素的新晶型及其制备方法 |
| WO2017219994A1 (zh) * | 2016-06-22 | 2017-12-28 | 山东亨利医药科技有限责任公司 | 9-氨基甲基取代的四环素类化合物的晶型及其制备方法 |
| CN111060641B (zh) * | 2019-12-27 | 2020-10-23 | 瀚晖制药有限公司 | 一种注射用替加环素中9-硝基米诺环素的检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5675030A (en) * | 1994-11-16 | 1997-10-07 | American Cyanamid Company | Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound |
| UA83266C2 (en) * | 2003-12-08 | 2008-06-25 | Уайет | Oxazole derivatives of tetracyclines |
| AR057033A1 (es) * | 2005-05-27 | 2007-11-14 | Wyeth Corp | Tigeciclina y metodos para preparar 9-nitrominociclina |
| AR057032A1 (es) | 2005-05-27 | 2007-11-14 | Wyeth Corp | Tigeciclina y metodos de preparacion |
| AR057649A1 (es) | 2005-05-27 | 2007-12-12 | Wyeth Corp | Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas |
| AR057324A1 (es) * | 2005-05-27 | 2007-11-28 | Wyeth Corp | Tigeciclina y metodos para preparar 9-aminominociclina |
| AR057034A1 (es) * | 2005-05-27 | 2007-11-14 | Wyeth Corp | Metodos para purificar tigeciclina |
| DE202007019460U1 (de) | 2006-04-24 | 2012-10-24 | Teva Pharmaceutical Industries Ltd. | Kristalline Tigecyclin-Formen |
| WO2008066935A2 (en) | 2006-11-29 | 2008-06-05 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of tigecycline and processes for preparation thereof |
| EP2178827A1 (en) | 2007-06-21 | 2010-04-28 | Sandoz AG | Crystalline solid forms |
| CN101386582A (zh) * | 2007-09-14 | 2009-03-18 | 上海来益生物药物研究开发中心有限责任公司 | 替加环素盐及其制备方法 |
-
2008
- 2008-11-12 US US12/742,706 patent/US8252946B2/en active Active
- 2008-11-12 EP EP08849962.9A patent/EP2220033B1/en active Active
- 2008-11-12 CA CA2704536A patent/CA2704536C/en not_active Expired - Fee Related
- 2008-11-12 WO PCT/EP2008/065398 patent/WO2009062963A1/en not_active Ceased
- 2008-11-12 CN CN200880116248.7A patent/CN101861300B/zh active Active
- 2008-11-12 JP JP2010533564A patent/JP5574967B2/ja active Active
- 2008-11-12 ES ES08849962.9T patent/ES2532880T3/es active Active
- 2008-11-12 SI SI200831397T patent/SI2220033T1/sl unknown
-
2010
- 2010-04-29 IL IL205451A patent/IL205451A0/en active IP Right Grant
-
2012
- 2012-07-17 US US13/550,665 patent/US20130012481A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW442295B (en) | Stable freeze-dried pharmaceutical composition | |
| JP2004533999A5 (enExample) | ||
| JP2011502997A5 (enExample) | ||
| JP2005518361A5 (enExample) | ||
| JP5576693B2 (ja) | 経皮吸収促進剤、および該経皮吸収促進剤を含有する経皮製剤 | |
| JP2006182786A5 (enExample) | ||
| CN1223347C (zh) | 注射用西洛他唑水性制剂 | |
| BR112015012460B1 (pt) | Formulação estabilizada de pemetrexede | |
| US20110224265A1 (en) | Gel containing pirfenidone | |
| JP2019511497A5 (enExample) | ||
| JP2011026348A5 (enExample) | ||
| JP2011503142A5 (enExample) | ||
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| JP2009517411A5 (enExample) | ||
| JP2011516544A5 (enExample) | ||
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2013529205A (ja) | 注射用イブプロフェン医薬組成物 | |
| JP2008545777A5 (enExample) | ||
| WO2008085674A1 (en) | Pharmaceutical compositions comprising celecoxib co-crystals | |
| CN1972899A (zh) | L－鸟氨酸·柠檬酸盐结晶 | |
| JPH10338638A (ja) | 損傷皮膚修復用製剤 | |
| JP4815867B2 (ja) | 安定化された固形製剤 | |
| CN104173321B (zh) | 制备通过外用贴剂给药的、具有消炎镇痛活性的药物组合物的方法，及以此获得的组合物 | |
| CA3137265A1 (en) | A stable, ready to use aqueous pharmaceutical composition of pemetrexed | |
| JPS58152811A (ja) | インドメタシン点眼組成物 |